Kirsten Eibl‐Lindner

Papers

Total Citations

H-Index

About

Kirsten Eibl‐Lindner is a leading ophthalmology researcher whose work centers on the treatment of uveal melanoma, with a particular focus on eye-preserving radiation therapies. Her major contributions lie in evaluating the efficacy and safety of frameless, image-guided robotic radiosurgery as an alternative to traditional brachytherapy. In her landmark 2015 study, she demonstrated that robotic radiosurgery achieves high local tumor control and impressive eye retention rates, even for medium and large uveal melanomas—a population often considered challenging for conservative therapy. This work, cited 58 times, has helped establish radiosurgery as a viable option for patients seeking to avoid enucleation. Eibl‐Lindner has also critically examined treatment complications, notably in her 2017 study on secondary glaucoma, which compared outcomes between robotic radiosurgery and brachytherapy. By systematically analyzing side effects, she has provided essential guidance for optimizing patient selection and post-treatment monitoring. Her research, while focused on a specific ocular malignancy, has broader implications for radiation oncology and vision preservation. Eibl‐Lindner’s contributions are particularly valuable for clinicians and researchers striving to balance oncologic control with quality of life in ocular cancer care.